Specific congenital malformations after exposure to cyclophosphamide, epirubicin and 5-fluorouracil during the first trimester of pregnancy

Gynecologic and Obstetric Investigation

Volumn 71, Issue 2, 2011, Pages 141-144

  Leyder, Mina ^a   Laubach, Monika ^a   Breugelmans, Maria ^a   Keymolen, Katelijn ^a   De Greve, Jacques ^b   Foulon, Walter ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Breast cancer; Chemotherapy; Congenital malformations; Pregnancy

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; METHOTREXATE;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; EMBRYOPATHY; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; FOOT MALFORMATION; HAND MALFORMATION; HUMAN; INTRADUCTAL CARCINOMA; MICROGNATHIA; MULTIPLE CYCLE TREATMENT; PREGNANCY TERMINATION; PRENATAL EXPOSURE; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, DUCTAL, BREAST; CYCLOPHOSPHAMIDE; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; LIMB DEFORMITIES, CONGENITAL; MALE; MICROGNATHISM; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY TRIMESTER, FIRST;

EID: 79952441670     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000317264     Document Type: Article

References (9)

1. Giannakopoulou C, Manoura A, Hatzidaki E, et al: Multinodal cancer chemotherapy during the first and second trimester of pregnancy: a case report. Eur J Obstet Reprod Biol 2000; 91: 95-97. (Pubitemid 30246028)
2. Paladini D, Vassallo M, D'Armiento MR, et al: Prenatal detection of multiple fetal anomalies following inadvertent exposure to cyclophosphamide in the first trimester of pregnancy. Birth Defects Res A Clin Mol Teratol 2004; 70: 99-100. (Pubitemid 38295841)
3. Vaux KK, Kahole NCO, Jones KL: Cyclophosphamide, methotrexate, and cytarabine embryopathy: is apoptosis the common pathway? Birth Defects Res Clin Mol Teratol 2003; 67: 403-408. (Pubitemid 38221987)
4. Paskulin GA, Zen PRG, Lapagesse de Camargo Pinto L, Rosa R, Graziadio C: Combined chemotherapy and teratogenicity. Birth Defects Res Clin Mol Teratol 2005; 73: 634-637. (Pubitemid 41428683)
5. Greenberg LH, Tanaka KR: Congenital anomalies probably induced by cyclophosphamide. JAMA 1964; 188: 423-426.
6. Di Fonzo LA, O'Connell TX: Breast cancer in pregnancy and lactation. Surg Clin North Am 1996; 76: 267-279.
7. Mir O, Berveiller P, et al: Chemotherapy for breast cancer during pregnancy: is epirubicine safe? Ann Oncol 2008; 19: 1814-1815.
8. Enns GM, Roeder E, Chan RT, Ali-Khan Catts Z, et al: Apparent cyclophosphamide (Cytoxan) embryopathy: a distinct phenotype? Am J Med Genet 1999; 86: 237-241. (Pubitemid 29465869)
9. Fenig E, Mishaeli M, Kalish Y, Lishner M: Pregnancy and radiation. Cancer Treat Rev 2001; 27: 1-7. (Pubitemid 32229681)